Adele Hite, PhD, MPH, RD coordinated the effort to get this clinical guidelines document to the point where it is publishable. Her efforts were nothing short of miraculous.
We have formed a board of advisers made up of experienced clinical practitioners and experts in the field to help us get this work done. Currently this board consists of David Cavan, MD, FRCP; Mark Cucuzzella MD, FAAFP; Robert Cywes, MD, PhD; Georgia Ede, MD; Gary Fettke, MB, BS, FRACS, FAOrthA; Brian Lenzkes, MD; Timothy D. Noakes, MD, DSc; Bret Scher, MD; Franziska Spritzler, RD, CDE; David Unwin, FRCGP; Eric C. Westman, MD, MHS; and William S. Yancy, Jr., MD, MSH. You can learn more about the Clinicians Committee and the Advisory Board here.
Work is now underway to generate condition-specific addenda for these Clinical Guidelines. It is clear that for certain chronic diseases the general intervention is not always enough. Nuances and caveats often exist that can make the intervention more successful. We will be starting with an addendum for Type 2 Diabetes. After that we will start focusing on cardiovascular disease, neurological disorders, and all the other chronic diseases for which this protocol is appropriate.
This Clinical Guidelines document will be updated from time to time as the science evolves. If you download or print this document out it is imperative that you return to this page regularly to ensure that you have the latest version. Scroll to the bottom to find links to the pdf versions and the various language translations.
Patient safety and support is of the highest importance. For practitioners who do not have prescribing/de-prescribing privileges, this means ensuring that all patients using therapeutic carbohydrate restriction are assisted in adjusting medications as needed by a professional trained in this process.
Read the ‘Statement of Support', then please complete the form if you would like to have your name listed on there as well.